M et P Pharma   Report issue

For profit Phase 2
Founded: Stans Switzerland (1987)
Status: No NME R&D (1987)

Organization Overview

First Clinical Trial
2008
NCT00647868
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

M et P Pharma AG

Active Ingredients

Drugs in Phase 2 Trials (1)

testosterone (delatestryl) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypogonadism (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1